ROSEVILLE, Minn., May 17, 2022
/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a
plant-based synthetic biology company, today announced that
management will participate in the following upcoming investor
conferences:
H.C. Wainwright Global Investment Conference
Date: May 25, 2022
Time: 11:30 am ET
Webcast: https://journey.ct.events/view/dd5ae7e1-6b52-430b-b9d8-504d330d80ad
LD Micro Invitational (XII)
Date: June 8, 2022
Time: 7:30 am ET
Webcast: https://ldinv12.mysequire.com
To schedule a meeting with management, please reach out to
investors@calyxt.com.
The presentations will be available for viewing and replay from
the Investors section of Calyxt's website at www.calyxt.com.
About Calyxt
Calyxt (Nasdaq: CLXT) is a plant-based synthetic biology
company. The Company leverages its proprietary PlantSpring™
technology platform to engineer plant metabolism to produce
innovative high value plant-based chemistries for use in customers'
materials and products. As plant-based solutions, the Company's
synthetic biology products can be used in helping customers meet
their sustainability targets and financial goals. Calyxt's
diversified offerings are primarily delivered through its
proprietary BioFactory™ production system. For more information,
visit www.calyxt.com.
PlantSpring, BioFactory, Plant Cell Matrix™, and the Calyxt logo
are trademarks of Calyxt, Inc. Any other trademarks belong to their
respective owners.
Contacts
|
Calyxt Media
Contact:
|
|
Calyxt Investor
Relations Contact:
|
|
David Rosen/ John
Garabo/ Michael Barron Argot Partners
(212)
600-1902
media@calyxt.com
|
|
Kimberly Minarovich/
Cameron Willis
Argot Partners
(212)
600-1902
investors@calyxt.com
|
|
|
|
|
Calyxt Business
Development Contact:
|
|
|
|
Gerry Nuovo
Senior Vice President
of Business Development
(612)
427-7881
contact@calyxt.com
|
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/calyxt-to-present-at-upcoming-conferences-301548398.html
SOURCE Calyxt, Inc.